These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 302143)

  • 1. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
    Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
    Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
    Jacobs SA; Santicky MJ
    Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

  • 6. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
    Von Hoff DD; Penta JS; Helman LJ; Slavik M
    Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
    Sadée W
    Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
    Schremi W; Lohrmann HP
    Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.
    Abelson HT; Ensminger W; Rosowsky A; Uren J
    Cancer Treat Rep; 1978 Oct; 62(10):1549-52. PubMed ID: 309355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results and pharmacokinetic aspects of methotrexate therapy in high doses].
    Lenzhofer R; Jaschek I; Breyer S; Graninger W; Moser K
    Acta Med Austriaca Suppl; 1979; 6():331-3. PubMed ID: 318045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
    Paparopoli G; Agostara B; Di Girolamo G
    Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
    Howell SB; Krishan A; Frei E
    Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
    Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S
    Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of solid tumors using high-dose methotrexate and citrovorum factor].
    Baumgartner G; Heinz R; Karrer K; Pridun N; Lutz D
    Osterr Z Onkol; 1977; 3(5-6):141-8. PubMed ID: 300863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate with leucovorin rescue.
    Akahoshi M
    Cancer Nurs; 1978 Aug; 1(4):319-25. PubMed ID: 307982
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
    Stoller RG; Kaplan HG; Cummings FJ; Calabresi P
    Cancer Res; 1979 Mar; 39(3):908-12. PubMed ID: 311683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.